UnknownPhase 2

The Prehospital Administration of Normobaric Oxygen in Suspected Stroke

China100 participantsStarted 2022-01-21

Plain-language summary

The primary purpose of this study is to explore the feasibility and safety of normobaric oxygen therapy (NBO) under pre-hospital condition in patients with suspected stroke.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Age 18 years or more.
✓. Suspected stroke screened by the "Gaze- Face Arm Speech Time" scale (G-FAST score ≥ 1).
✓. Within 24 hours of symptom onset
✓. SpO2 \> 94%.

Exclusion criteria

✕. Coma: Glasgow coma score (GCS) \< 8.
✕. Hypoglycemia: Blood glucose \< 2.8mmol /L.
✕. Known history of seizure.
✕. Recent stroke or brain trauma within past 30 days.
✕. Previous Modified Rankin Scale (mRS) ≥2.
✕. Rapid improvement of neurological dysfunction (deficit present less than 15 min).
✕. Unstable vital signs.
✕. Known respiratory distress, respiratory dysfunction, or any contraindications to high-flow oxygen inhalation therapy.

What they're measuring

Time intervals of the prehospital transportation process

Timeframe: Day 1

Trial details

NCT IDNCT05351073

SponsorCapital Medical University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-07-20

View on ClinicalTrials.gov More Acute Stroke trials